BCL2 and neoplasm: The protein expression of Bcl-2, a traditional anti-apoptotic factor in progressive tumour cells that can be down-regulated by miR-34a, was found to be significantly reduced in tumour tissues of mice treated with PCA/miR-34a compared to controls, where tumour cells also showed reduced proliferation and increased apoptosis [39].